Zura Bio Limited
NASDAQ:ZURABiotechnology
+$0.07 today
- Market cap
- $92.96M
- Beta
- 0.03
- P/E (TTM)
- -5.5
- EPS (TTM)
- -$0.67
Volume 3.02M
Average 0.75M
ZURA Property, Plant & Equipment (Net)
Physical long-term assets such as land, buildings, and machinery, net of accumulated depreciation.
Zura Bio LimitedNASDAQ: ZURA
Property, Plant & Equipment (Net) · Q1 FY2026 · quarter ended Mar 2026
Property, plant & equipment (net) rises 17.9% from a year ago
Property, plant & equipment (net) stood at $125K at the end of Q1 FY2026, up 17.9% from a year earlier and down 0.8% from the prior quarter.
Context
- Property, plant & equipment (net) amounted to 0.1% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Property, plant & equipment (net) increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether property, plant & equipment (net) keeps rising in the next quarterly balance sheet after a +17.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Property, Plant & Equipment (Net) history
USD · from the balance sheet
- Latest · FY2025
- 126K USD
- Year-over-year change
- +38.5%
| Period | Period end | Property, Plant & Equipment (Net) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 126K | +38.5% |
| FY2024 | 2024-12-31 | 91K | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2022-03-31 | 0 | — |
Property, Plant & Equipment (Net) vs competitors
How ZURA compares with its peers on the latest reported figures
- ZURA's Mar 2026 property, plant & equipment (net) of $125K is the 10th highest of the 11 companies compared; the peer median is $28.38M.
- Its year-over-year change of +17.9% is the 2nd highest of 11, against a peer median of -11.0%.
- Property, plant & equipment (net) amounts to 0.1% of total assets for ZURA, versus a peer median of 12.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $4.17B | +89896.8% | -9.7% | 1.9% | |
| Mar 2026 | $69.55M | -9.3% | +34.8% | 22.1% | |
| Mar 2026 | $34.72M | -22.2% | -16.1% | 25.7% | |
| Mar 2026 | $32.1M | +1.8% | -12.7% | 14.4% | |
| Mar 2026 | $30.27M | -2.0% | -1.4% | 17.0% | |
| Mar 2026 | $26.5M | -23.4% | -14.8% | 10.8% | |
| Mar 2026 | $18.73M | -12.7% | -7.8% | 29.1% | |
| Mar 2026 | $2.58M | -18.7% | -11.5% | 1.1% | |
| Mar 2026 | $269K | -57.2% | +12.1% | 0.3% | |
ZURAZura Bio Limited | Mar 2026 | $125K | +17.9% | — | 0.1% |
SGMTSagimet Biosciences Inc. | Mar 2026 | $39K | +2.6% | -28.3% | 0.0% |
| Peer median (excluding ZURA) | $28.38M | -11.0% | -10.6% | 12.6% | |
Competitors are the stored peer set for ZURA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Zura Bio Limited
NASDAQ:ZURA
Intrinsic Alpha fair value
Locked
Current Price
$0.97
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.